The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Frequency Therapeutics, Inc.

New York, New York – (Newsfile Corp. – July 30, 2021) – Vincent Wong’s law firms announce that they have initiated a class action lawsuit on behalf of investors who have purchased Frequency Therapeutics, Inc. (“Frequency Therapeutics”) became. ) (NASDAQ: FREQ) between November 16, 2020 and March 22, 2021.

If you have suffered a loss, contact us at the link below. There are no costs or obligations for you.

Allegations against FREQ include that the company made materially false and / or misleading information and / or failed to disclose: The company’s Phase 2a study results were not what the company expected because the results showed no discernible difference between FX-322 and the placebo. Despite the disappointing results, the company continued the Phase 2a study and released positive statements in earnings calls, press releases, SEC filings and pharmaceutical presentations about the potential of FX-322. Those statements have seriously misled the market and artificially inflated the value of Frequency’s common stock.

If you have suffered harm at Frequency Therapeutics, you can apply until August 2, 2021 for the court to appoint you as the lead plaintiff. Your ability to partake in a recovery does not require you to be the lead plaintiff.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities disputes related to financial fraud and shareholder violations. Lawyer advertising. Previous results do not guarantee similar results.

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Telephone number. 212.425.1140
Fax. 866.699.3880

To view the source version of this press release, please visit

Comments are closed.